CITIUS ONCOLOGY INC (CTOR:NASDAQ)
$0.675 0.015 (2.2727%)
Analysed CITIUS ONCOLOGY INC (CTOR:NASDAQ) News Sources
Citius Oncology Provides Commercial Update on LYMPHIR™ Launch Highlighting Early Adoption and Expanding Clinical Development
31-03-2026
yahoo.com
Citius Oncology to Participate in USCLC Annual Workshop 2026, Highlighting LYMPHIR™ in Discussions with Leading Cutaneous Lymphoma Experts
24-03-2026
yahoo.com
Citius Oncology Announces Positive Topline Results from Investigator‑Initiated Phase 1 Study of LYMPHIR™ in Combination with Pembrolizumab in Relapsed or Refractory Gynecologic Cancers
10-03-2026
yahoo.com
Citius Pharma (CTXR) Becomes Revenue-Generating With the Commercial Launch of LYMPHIR
06-03-2026
yahoo.com
Citius Oncology Announces Preliminary Topline Phase 1 Data from Study of LYMPHIR™ (E7777) Dosing Prior to Commercial CAR‑T Therapy in High‑Risk Diffuse Large B‑Cell Lymphoma
04-03-2026
yahoo.com
Citius Oncology (CTOR) Expands LYMPHIR Distribution to Europe Through Exclusive Agreement With Uniphar
24-02-2026
yahoo.com
Citius Pharmaceuticals, Inc. Announces First Reported Revenue Following Successful Launch of LYMPHIR™
13-02-2026
yahoo.com
Citius Oncology, Inc. Announces First Reported Revenue Following Successful Launch of LYMPHIR™
13-02-2026
yahoo.com
Citius Oncology and Uniphar sign European distribution deal for Lymphir
12-02-2026
pharmaceutical-technology.com
Citius Oncology Expands International Distribution of LYMPHIR™ to European Union Through Exclusive Agreement with Uniphar
11-02-2026
yahoo.com
What is the current price of CITIUS ONCOLOGY INC (CTOR:NASDAQ)?
The current price of CITIUS ONCOLOGY INC (CTOR:NASDAQ) is $0.675.
CITIUS ONCOLOGY INC (CTOR:NASDAQ) absolute price change since previous trading day?
The absolute price change of CITIUS ONCOLOGY INC (CTOR:NASDAQ) since the previous trading day is $0.015.
CITIUS ONCOLOGY INC (CTOR:NASDAQ) percentage price change since previous trading day?
The percentage price change of CITIUS ONCOLOGY INC (CTOR:NASDAQ) since the previous trading day is 2.2727%.
What is the most recent average sentiment score for CITIUS ONCOLOGY INC (CTOR:NASDAQ)?
The most recent average sentiment score for CITIUS ONCOLOGY INC (CTOR:NASDAQ) is 88 out of 100.
What is the most recent average sentiment for CITIUS ONCOLOGY INC (CTOR:NASDAQ)?
The most recent sentiment for CITIUS ONCOLOGY INC (CTOR:NASDAQ) is .
SEC-8K** Filing Available For CITIUS ONCOLOGY INC (CTOR:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.